LXRX (Lexicon Pharmaceuticals) Total Liabilities: $65.96 Mil (As of Mar. 2026)


LXRX Lexicon Pharmaceuticals Inc LXRX
57 GF Score
Price $2.27
GF Value $8.37
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Lexicon Pharmaceuticals Total Liabilities?

Lexicon Pharmaceuticals LXRX -4.02% 57 Total Liabilities is $65.96 Mil as of Mar. 2026. GuruFocus rates LXRX with a GF Score™ of 57/100 and a GF Value™ of $8.37 (Possible Value Trap). The stock has 3 warning signs investors should review.

Lexicon Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 was $65.96 Mil.

Lexicon Pharmaceuticals's quarterly Total Liabilities declined from Sep. 2025 ($85.77 Mil) to Dec. 2025 ($77.45 Mil) and declined from Dec. 2025 ($77.45 Mil) to Mar. 2026 ($65.96 Mil).

Lexicon Pharmaceuticals's annual Total Liabilities increased from Dec. 2023 ($136.32 Mil) to Dec. 2024 ($152.47 Mil) but then declined from Dec. 2024 ($152.47 Mil) to Dec. 2025 ($77.45 Mil).

Lexicon Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Lexicon Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexicon Pharmaceuticals Total Liabilities Chart

Lexicon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.31 77.18 136.32 152.47 77.45

Lexicon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 174.64 96.14 85.77 77.45 65.96
LXRX
57GF Score
Lexicon Pharmaceuticals Inc LXRX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lexicon Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lexicon Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=20.867+(56.582+-7.105427357601E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=77.45

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=184.987-107.538
=77.45

Lexicon Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.898+(56.065+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=65.96

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=268.819-202.856
=65.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $65.96 Mil mean?
Lexicon Pharmaceuticals (LXRX) has a Total Liabilities of $65.96 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lexicon Pharmaceuticals and its competitors.
Is Lexicon Pharmaceuticals' Total Liabilities too high?
Lexicon Pharmaceuticals' current Total Liabilities is $65.96 Mil. Overall, Lexicon Pharmaceuticals has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lexicon Pharmaceuticals' Total Liabilities compare to CGEM and WVE?
Lexicon Pharmaceuticals' Total Liabilities of $65.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lexicon Pharmaceuticals and its competitors. Lexicon Pharmaceuticals's current Total Liabilities is $65.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lexicon Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lexicon Pharmaceuticals (LXRX) is currently considered Possible Value Trap. The stock's GF Value™ is $8.37, compared to a current price of $2.27 — trading 72.9% below its estimated fair value. The current Total Liabilities is $65.96 Mil. Lexicon Pharmaceuticals' overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Lexicon Pharmaceuticals (LXRX), the current Total Liabilities is $65.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lexicon Pharmaceuticals (LXRX) Overvalued in 2026?

Based on GuruFocus' analysis, Lexicon Pharmaceuticals stock appears to be undervalued. The current stock price of $2.27 is trading 72.9% below its estimated GF Value™ of $8.37. GuruFocus considers Lexicon Pharmaceuticals to be Possible Value Trap.

Key valuation signals for LXRX:

  • Total Liabilities: $65.96 Mil
  • GF Value™: $8.37 vs. price of $2.27 (72.9% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the LXRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lexicon Pharmaceuticals Business Description

Address 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
57GF Score

Get the complete analysis for LXRX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.27
Price
$8.37
GF Value